Cargando…

Assessing the evidence on remdesivir

Detalles Bibliográficos
Autores principales:	Núñez, Isaac, Soto-Mota, Adrian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612723/ https://www.ncbi.nlm.nih.gov/pubmed/34838223 http://dx.doi.org/10.1016/S1473-3099(21)00693-9

Ejemplares similares

Assessing the evidence on remdesivir
por: Trøseid, Marius, et al.
Publicado: (2021)

Remdesivir and COVID-19
por: Glaus, Matthew J, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Wang, Lei-Yun, et al.
Publicado: (2020)

Remdesivir and COVID-19
por: Dennis, Alicia
Publicado: (2020)

Remdesivir and COVID-19
por: Edwards, Jessie K, et al.
Publicado: (2020)

Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020)

Remdesivir therapy associated with Bradycardia in SARS‐CoV2
por: Kumar, Sabina, et al.
Publicado: (2021)

Remdesivir-Induced Liver Injury in a COVID-Positive Newborn
por: Kaur, Manjit, et al.
Publicado: (2022)

The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity
por: Shen, Yue, et al.
Publicado: (2021)

Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection
por: Sanchez-Codez, Maria Isabel, et al.
Publicado: (2021)

Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19
por: Ader, Florence, et al.
Publicado: (2022)

Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity
por: Núñez, Isaac
Publicado: (2022)

Harm of early dexamethasone for COVID-19 and bias in randomized trials
por: Núñez, Isaac, et al.
Publicado: (2023)

Assessing Evidence Quality for Endovascular Arteriovenous Fistulas
por: Shimamura, Yoshinosuke, et al.
Publicado: (2022)

Hospitalization as an outcome in ambulatory COVID-19 trials—not applicable in every setting
por: Núñez, Isaac, et al.
Publicado: (2022)

Remdesivir
por: Bakheit, Ahmed H., et al.
Publicado: (2023)

Is there evidence of intra-uterine vertical transmission potential of COVID-19 infection in samples tested by quantitative RT-PCR?
por: Cheruiyot, Isaac, et al.
Publicado: (2020)

Benefit-risk assessment for remdesivir in COVID-19
Publicado: (2020)

Sicily statement on classification and development of evidence-based practice learning assessment tools
por: Tilson, Julie K, et al.
Publicado: (2011)

Assessing government responsibility for COVID-19 deaths
por: Mundt, Adrian P
Publicado: (2021)

Remdesivir in Breastfeeding
por: Sadati, Elham, et al.
Publicado: (2022)

Remdesivir – Current evidence & perspective in management of COVID-19 infection
por: Bajpai, Jyoti, et al.
Publicado: (2021)

Remdesivir Use in the Real-World Setting: An Overview of Available Evidence
por: Akinosoglou, Karolina, et al.
Publicado: (2023)

Meta-research studies in surgery: a field that should be encouraged to assess and improve the quality of surgical evidence
por: Lozada-Martinez, Ivan D., et al.
Publicado: (2023)

Remdesivir: Infusion site reaction following extravasation of remdesivir: case report
Publicado: (2021)

Remdesivir-associated bradycardia
por: Ching, Patrick R, et al.
Publicado: (2021)

Remdesivir: Quo vadis?()
por: De Clercq, Erik
Publicado: (2021)

Anaphylaxis Due to Remdesivir
por: Hopkins, Brian J., et al.
Publicado: (2021)

Remdesivir: First Approval
por: Lamb, Yvette N.
Publicado: (2020)

Remdesivir and COVID-19
por: Ferrara, Francesco, et al.
Publicado: (2020)

Remdesivir for COVID-19
Publicado: (2020)

Total synthesis of remdesivir()
por: Kumar Palli, Kishore, et al.
Publicado: (2022)

Combined Cytokine Scores Assessed at Emergency Department Presentation Predicts COVID-19 Critical Illness
por: Michael Henry, Brandon, et al.
Publicado: (2021)

Remdesivir: Intrahepatic cholestasis of pregnancy following compassionate use of remdesivir: case report
Publicado: (2020)

Ideology over evidence?
por: Jauhar, Sameer, et al.
Publicado: (2018)

No evidence for cardiotoxicity of miltefosine()
por: Dorlo, Thomas P.C.
Publicado: (2022)

Pfhrp2 Deletions in the Democratic Republic of Congo: Evidence of Absence, or Absence of Evidence?
por: Woodrow, Charles J, et al.
Publicado: (2017)

Covid conspiracies: misleading evidence can be more damaging than no evidence at all
por: McManus, Sally, et al.
Publicado: (2022)

Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
por: Lin, Hui Xian Jaime, et al.
Publicado: (2021)

Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
por: Furlan, Leonardo
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5kj9blo181ordmguvrsnfhpshk